Las Vegas, NVNCT06901505Now EnrollingIRB Ready

Chronic Kidney Disease Clinical Trial in Las Vegas, NV

Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Las Vegas. Study-provided care at no cost to qualified participants.

Sponsored by Akebia Therapeutics

Quick Self-Assessment

See if you qualify for this Las Vegas location

Preparing your pre-screening questions...

Expert Care in Las Vegas

Access chronic kidney disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic kidney disease treatment provided free

Apply for This Las Vegas Location

Check if you qualify for this chronic kidney disease clinical trial in Las Vegas, NV

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Las Vegas

    Convenient for NV residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Las Vegas site if eligible
  4. 4Begin participation

About This Chronic Kidney Disease Study in Las Vegas

This is a multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the efficacy of vadadustat administered three times a week compared to standard of care erythropoiesis-stimulating agent for the treatment of anemia in in-center hemodialysis participants with end-stage kidney disease (ESKD). A subset of sites will participate in a red blood cell (RBC) sub-study where changes in the phenotype of RBCs in response to vadadustat treatment relative to methoxy polyethylene gly

Sponsor: Akebia Therapeutics

Who Can Participate

Inclusion Criteria

Adult participants ≥18 years of age.
Receiving outpatient in-center hemodialysis for ESKD at least three times a week.
Currently prescribed or meets criteria for ESA based on approved facility policy.
Hb \> 8 grams per deciliter (g/dl).
Serum ferritin ≥100 nanograms per milliliter (ng/mL) and transferrin saturation (TSAT) ≥20%.
Understands the procedures and requirements of the study and provides written informed consent and authorization for protected health information disclosure.
For selected sites, individuals who opt to participate in the RBC sub-study must meet the following inclusion criteria:
Currently prescribed or will be prescribed methoxy polyethylene glycol-epoetin beta.
Hb \<11.5 g/dL

Exclusion Criteria

Contraindication to receive vadadustat per United States prescribing information (USPI) as determined by the treating health care provider.
Concomitant use of any hypoxia-inducible factor prolyl hydroxylase inhibitor(HIF-PHI).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Las Vegas?

Yes, this clinical trial (NCT06901505) has an active research site in Las Vegas, NV that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Kidney Disease Treatment Options in Las Vegas, NV

If you're searching for chronic kidney disease treatment options in Las Vegas, NV, this clinical trial (NCT06901505) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Las Vegas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic kidney disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Las Vegas, NV

See all ankylosing spondylitis clinical trials recruiting in Las Vegas — not just this study.

Browse Ankylosing Spondylitis Trials in Las Vegas

Ready to Join in Las Vegas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Las Vegas, NV